Which one is better, niraparib or olaparib?

Niraparib and olaparib are two different PARP inhibitors used to treat certain types of cancer, especially ovarian cancer. Both drugs have shown promising efficacy in clinical trials. Assessment of efficacy depends on multiple factors, including the patient's specific condition, disease characteristics, genetic mutation status, and other relevant factors. The choice of which drug to use should be made by the physician based on the patient's specific situation and individualized assessment.

Niraparib is used as "maintenance" treatment in adults to prevent certain types of cancer from coming back. This includes cancer of the ovaries, fallopian tubes, or peritoneum (the membrane that covers the inside of the abdomen and covers some internal organs). Give niraparib after you have received chemotherapy (with cisplatin, oxaliplatin, carboplatin, or other similar products) and your cancer responds to this drug. Lynparza is a drug used for the maintenance treatment of advanced cancer in adults with BRCA mutations. It can inhibit poly(ADP-ribose) polymerase (PARP). BRCA1/2 mutations may genetically sensitize some forms of cancer and may confer resistance to other forms of cancer treatment. These cancers are sometimes uniquely fragile, and olaparib, which acts as an inhibitor of poly(ADP-ribose polymerase) (PARP), a cancer that is more sensitive to this treatment, may be beneficial. One potential advantage of niraparib is once-daily dosing, which may be more convenient for patients than the twice-daily dosing regimen of olaparib.

NiraparibThe original drug has been launched in China and is included in medical insurance, but reimbursement is limited to eligible patients. The price of a common specification100mg*30 capsules per box may be more than 5,000 yuan. The original niraparib drug marketed overseas is more expensive than domestically. There are also generic niraparib drugs produced in other countries. Their pharmaceutical ingredients are basically the same as those of the original niraparib drug sold domestically and abroad. The price of 100mg*30 tablets per box produced by a Bangladesh pharmaceutical factory may be more than 1,000 yuan (the price may fluctuate due to exchange rates).